Bull Rider

Bull Rider
Send Message
View as an RSS Feed
  • Can A Drone Save GoPro?  [View article]
    Send it investor relations, business development, with a confidential agreement.
    Jan 14, 2016. 07:41 AM | Likes Like |Link to Comment
  • Can A Drone Save GoPro?  [View article]
    please use soda stream...... :)
    Jan 14, 2016. 05:17 AM | Likes Like |Link to Comment
  • Can A Drone Save GoPro?  [View article]
    Gopro wants to survive- Gopro should buy DJI or other way around. They are complimentary! Otherwise they are drone dead. Has any one thought about legislature regarding drones? Privacy? Gopro entering the drone market is too late, they are or were going on and on about being a content company and now add drones to it.

    The problem with M&A is that Gopro will never buy DJI but DJI might want to buy GOPRO and then we will have a problem with some laws as drones are by nature invasive! Chinese drones enter us SPACE!!!!

    Amba BUYING GOPRO OR OTHERWAY around is also not happening as the synergies are too little.

    Either which way anyway we are beeped!

    Innovation is great and the early investors are rewarded for their risks while the stupid buy and hold investor who is smitten by greed but does not act and who buys when the early investors are exiting are beeped.....

    Sorry for my tirade but I did not win the power ball and my portfolio is tanking. Even though I have value stocks I still hold mistakes that I MADE in my earlier days aka. gopro, michael Chors, amba, MU, Cool, Soda stream and these dead weights are exactly that!
    Jan 14, 2016. 05:14 AM | Likes Like |Link to Comment
  • After Hours Gainers / Losers  [View news story]
    go private!
    Jan 14, 2016. 04:38 AM | Likes Like |Link to Comment
  • Ambarella's Short-Term Headwind Is Your Friend  [View article]
    The shorts search out the most riskiest stocks and gopro and amba belong to this group. Fundamentals aside, thy have made money and with 6 days to cover all you need is the NASDAQ to change direction, like today, and make a big move making AMBA and gopro great buys. But that is trading! As a buy and hold investor would you not be looking at fundamentals? Doesnt AMBA have great fundamentals?
    Jan 12, 2016. 05:51 AM | 1 Like Like |Link to Comment
  • Ambarella's Short-Term Headwind Is Your Friend  [View article]
    Therefore, it would be prudent to watch where the stock price of Ambarella settles in the next month.

    Now is a good time to buy AMBA, 12 month holding period. The fall Friday was totally blown out of proportion, the company has a PEG of 0.85 MAKING it a great buy. Last 12 Q were earnings and revenues beat. In the semiconductor space it has a relatively small market cap but it has first mover advantage and the current stock price does not relate to its relative almost market segment PE. Either it will be bought out or the stock price will rise subject to overall market performance. We should see 70-80 USD by end of Jan if the Nasdaq lifts off due to the short ratio of 6.4. Time to fry the shorts (48% shorted)...
    Jan 11, 2016. 08:40 AM | Likes Like |Link to Comment
  • ASH-tainted investors shun Agios Pharma despite positive early-state data; shares slump 13% in early trading  [View news story]
    Agios a buy with stop loss at 48 USD.
    Dec 17, 2015. 06:06 AM | Likes Like |Link to Comment
  • MEI Pharma: ASH Abstract Data Supports Advancement Of Pracinostat In MDS And AML  [View article]
    On a weekly chart it has been trading in this range: 1.46 to 1.91. So my exceptions are that it goes back to 1.91 and higher. It might break out before falling back. Last week was unusually high volume selling that last occurred the week after the stock fell from 6.27 to 1.71. It might break out as the bolinger bands have narrowed signalling low volatility and also the probability of a squeeze out. The OBV another volume signal is positive good sign for upwards movement and the Chaikin_mf is at trending up another buy signal indicator. RSI has been rising since July. Lastly on new new low has been created.
    Daily chart- close 1.62, upside target 1.91 (17.9%), Stop loss 1.5 (7.41%)
    Dec 17, 2015. 05:34 AM | 1 Like Like |Link to Comment
  • MEI Pharma: ASH Abstract Data Supports Advancement Of Pracinostat In MDS And AML  [View article]
    "Sitting at ~$60M market cap, near cash on hand, I expect shares to run-up in anticipation of ASH and much higher following results and analyst feedback. "

    Stock Doctor please do comment as the stock has not run up and the results were not so exciting judging from the stock price?
    At 1.56 its about to fall off the cliff!
    Dec 15, 2015. 11:41 AM | Likes Like |Link to Comment
  • Calling all value investors: Airline stocks head into 2016 with upside  [View news story]
    PE of the industry is low. The stocks are not undervalued. The price of oil falling is bad for airlines as they are all hedged, hence the question is at what price are they buying? If the economy is improving then travel will increase and then airlines are interesting as long as they can successfully raise prices. Is there not over capacity in the airline sector? I like American airline. Last reading forward PE 7.29 and other operating metrics are indicating a turnaround.
    Dec 14, 2015. 04:12 AM | Likes Like |Link to Comment
  • MEI Pharma: ASH Abstract Data Supports Advancement Of Pracinostat In MDS And AML  [View article]
    News has come and gone but the stock is is a duck, what now?
    Dec 9, 2015. 03:24 AM | 2 Likes Like |Link to Comment
  • Value And Taxes: Breaking Down The Pfizer-Allergan Deal  [View article]
    they use a moving average when the deal is closed i.e signing and then calculate what the stock portion is at that moving average price. Since it is 99% shares its pretty simple. Keep buying AGN as that is the upside potenial of the stock if the deal closes.
    Nov 24, 2015. 08:50 AM | Likes Like |Link to Comment
  • Will the new inversion rules derail a Pfizer-Allergan deal?  [View news story]
    Nov 23, 2015. 04:54 AM | Likes Like |Link to Comment
  • Value And Taxes: Breaking Down The Pfizer-Allergan Deal  [View article]
    Thanks for another excellent written article. The market does not seem to be buying your argument? Is there a reason for it? What will happen to the dividend? How will it be taxed assuming the inversion goes through?
    Nov 23, 2015. 04:38 AM | Likes Like |Link to Comment
  • MEI Pharma: ASH Abstract Data Supports Advancement Of Pracinostat In MDS And AML  [View article]
    MEIP should hit 6.42 USD on news of becoming a take over target.

    Hi Doc, I really hope so. The retracements on the charts show 3.54 USD as first resistance, 4.67 USD as second resistance level. The stock is trading below the 13 and 50 day moving average and these resistance levels have to be broken first.
    If I remove all the noise and looked at a monthly chart then it gets really interesting.
    Resistance levels
    1. 2.90 USD 13 month moving average
    2. 6.42 USD 38.2% fib retracement and 50 month moving average (5.98 USD)
    3. 9.33 USD 61.8% fib retracement
    On the downside- we are at the bottom and the stock has been literally consolidating after hitting its low of 1.5 USD on March, 2009. It hit 1.47 USD on August 2015.
    Since Nov 2012 there has been a surge in monthly volumes from 50-70000 shares per month to more than a million. Did they do a capital increase? Previously since the volume was so low the stock was very volatile.
    Nov 2012 the stock rallied on volumes of 1.6 million shares.
    Since Dec 2014 the average monthly volume is 8 million shares.
    The volume indicators OBV is negative and that is a leading indicator so no reprieve at present.
    The money flow indicator Chaikin MF is at -0.45. Only when that starts moving above 0.5 is an upward trend confirmed.
    Since this is a monthly analysis my assumptions are that it will take some really good news to move this stock or it will move gradually over the next 6 months towards 6.28 USD.
    The last 7 months the stock has moved within a range of 1.47 and 2.44 USD. This month it hit 2.12 USD but the sellers killed it pushing it back to a low of 1.60 USD. On a monthly basis a close above 2.44 USD could be a start of a rally and a close below 1.47 USD would move the stock lower.
    The MACD and its histogram are useless on a monthly chart.
    Attached are three charts of MEIP
    The first is 22.04.14 when they were granted orphan status and the stock tanked shortly after.

    The second is 27.03.15 showing how the stock performed on a weekly basis since June 2010. As you can see on that chart I showed that it would fall to 1.8 USD which it did. But more importantly the the fall came from 6.06 USD which is close to my price target if they dont go bankroll first.

    The last chart is a monthly chart 17.11.15 on which my current analysis is based.

    Nov 17, 2015. 04:18 AM | 3 Likes Like |Link to Comment